Alzheimer’s disease (AD) is a neurodegenerative disorder, which is likely to start as mild cognitive impairment (MCI) several years before its fullblown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to observe a signifi cant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests. Furthermore, these structural measures correlate with electrophysiological parameters of pattern electroretinogram, refl ecting integrity of the innermost retinal layers, but not with those of the visual evoked potentials, refl ecting activity of the post-chiasmatic visual pathway. The latter evidence suggests that RNFL thickness reduction is related to neuronal degeneration in the ganglion cell layer and not to a retrograde degeneration from the post-chiasmatic visual pathway. These data suggest a possible role of OCT in monitoring the progression of AD and in assessing the effectiveness of purported AD treatments.

Coppola, G., Parisi, V., Manni, G., Pierelli, F., Sadun, A.a. (2016). Optical coherence tomography in alzheimer’s disease. In OCT in Central Nervous System Diseases: The Eye as a Window to the Brain (pp. 123-142). Springer International Publishing [10.1007/978-3-319-24085-5_7].

Optical coherence tomography in alzheimer’s disease

Parisi V.;Manni G.;
2016-01-01

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder, which is likely to start as mild cognitive impairment (MCI) several years before its fullblown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to observe a signifi cant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests. Furthermore, these structural measures correlate with electrophysiological parameters of pattern electroretinogram, refl ecting integrity of the innermost retinal layers, but not with those of the visual evoked potentials, refl ecting activity of the post-chiasmatic visual pathway. The latter evidence suggests that RNFL thickness reduction is related to neuronal degeneration in the ganglion cell layer and not to a retrograde degeneration from the post-chiasmatic visual pathway. These data suggest a possible role of OCT in monitoring the progression of AD and in assessing the effectiveness of purported AD treatments.
2016
Settore MED/30 - MALATTIE APPARATO VISIVO
English
Rilevanza internazionale
Capitolo o saggio
Alzheimer’s disease; Electroretinogram; Mild cognitive impairment; Optical coherence tomography; Psychometric testing; Retina
Coppola, G., Parisi, V., Manni, G., Pierelli, F., Sadun, A.a. (2016). Optical coherence tomography in alzheimer’s disease. In OCT in Central Nervous System Diseases: The Eye as a Window to the Brain (pp. 123-142). Springer International Publishing [10.1007/978-3-319-24085-5_7].
Coppola, G; Parisi, V; Manni, G; Pierelli, F; Sadun, Aa
Contributo in libro
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/314765
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact